- Headquarters
- San Francisco, California
- Employees
- 1–10
- Founded
- 2022
- Business Model
- B2B
- Website
- ageddiagnostics.com
- Last Round
- Pre-SeedAug 2025
- Rounds
- 1
Indexed holds 1 funding round and 3 investors for this company. The full record is or through the API.
About
AGED (Active Genomes Expressed) Diagnostics is developing accurate, non-invasive blood tests for the early detection and staging of liver disease. Its genomics-based assays detect circulating genetic signatures associated with conditions such as fibrosis and steatohepatitis (NASH) and liver cancer, aiming to give clinicians an earlier, more affordable alternative to biopsy and current screening methods so patients can access intervention sooner.
Summary
It lists 1–10 employees. Its most recent funding was a Pre-Seed round in Aug 2025. Investors include TEDCO, Plug and Play and Central Texas Angel Network.
Tech & App Stack
3 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Aug 2025
Investors
Similar Companies
China's leading blood products manufacturer
One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...
Global contract research organization providing comprehensive drug development and laboratory ser...
Specialty pharmaceutical company
Appears in
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/aged-diagnostics"><img src="https://indexed.vc/api/badge/company/aged-diagnostics" alt="AGED Diagnostics on Indexed.vc" width="260" height="76" /></a>